WESTFIELD CAPITAL MANAGEMENT CO LP Neurocrine Biosciences, Inc. Transaction History

WESTFIELD CAPITAL MANAGEMENT CO LP portfolio value:

$48.87M
portfolio value

WESTFIELD CAPITAL MANAGEMENT CO LP quarter portfolio value change:

+8.96%
quarter

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -12.98% -68.66K shares -2.67M $106.21 460.18K
Q2 2022 share Decrease -4.63% -25.64K shares -432K $97.48 528.84K
Q1 2022 share Decrease -21.49% -151.73K shares -8.16M $93.75 554.49K
Q4 2021 share Decrease -2.34% -16.95K shares -9.21M $84.63 706.22K
Q3 2021 share Increase +17.59% 108.18K shares 9.50M $95.91 723.17K
Q2 2021 share Increase +14.68% 78.74K shares 7.70M $97.32 614.99K
Q1 2021 share Increase +15.55% 72.16K shares 7.66M $97.25 536.25K
Q4 2020 share Increase +14.80% 59.83K shares 5.61M $95.85 464.08K
Q3 2020 share Increase +1.20% 4.78K shares -9.86M $96.16 404.25K
Q2 2020 share Decrease -38.37% -248.69K shares -7.36M $122 399.46K
Q1 2020 share Increase 0.00% 648.15K shares 56.09M $86.55 648.15K
Q2 2019 share Decrease -100.00% -316.54K shares -27.88M $84.43 0
Q1 2019 share Increase +120.22% 172.8K shares 17.62M $88.1 316.54K
Q4 2018 share Increase 0.00% 143.74K shares 10.26M $71.41 143.74K
Q3 2018 share Decrease -100.00% -184.74K shares -18.14M $122.95 0
Q2 2018 share Increase 0.00% 184.74K shares 18.14M $98.24 184.74K
Q4 2017 share Decrease -100.00% -383.09K shares -23.47M $77.59 0
Q3 2017 share Decrease -72.65% -1.01M shares -40.95M $61.28 383.09K
Q2 2017 share Increase +18.14% 215.10K shares 13.09M $46 1.40M
Q1 2017 share Decrease -14.93% -208.02K shares -2.59M $43.3 1.18M
Q4 2016 share Increase +10.95% 137.51K shares -9.67M $38.7 1.39M
Q3 2016 share Decrease -1.53% -19.58K shares 5.62M $50.64 1.25M
Q2 2016 share Decrease -3.26% -42.92K shares 5.82M $45.45 1.27M
Q1 2016 share Increase +7.93% 96.85K shares -16.96M $39.55 1.31M